Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  70,941 results for ""Drug development""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

  • Authors : Sawant-Basak A; Clinical Pharmacology and Pharmacometrics, AstraZeneca, Waltham, MA, USA.; Urva S

Subjects: Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Drug Development*/Drug Development*/Drug Development*/methods ; Pharmacology, Clinical*

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 902-913. Date of Electronic Publication: 2024 Jul 07.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacogenomics and pediatric drug development: science and political power. A narrative review.

Subjects: Pharmacogenetics*/Pharmacogenetics*/Pharmacogenetics*/methods ; Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Drug Development*/Drug Development*/Drug Development*/methods

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Dec; Vol. 25 (18), pp. 2367-2373. Date of Electronic Publication: 2024 Sep 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Drug Development*; Humans

  • Source: JACC. Heart failure [JACC Heart Fail] 2024 Nov; Vol. 12 (11), pp. 1803-1813. Date of Electronic Publication: 2024 Jul 10.Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The use of real-world data for clinical investigation of effectiveness in drug development.

  • Authors : Wang P; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.; Chow SC

Subjects: Drug Development*/Drug Development*/Drug Development*/statistics & numerical data ; Drug Development*/Drug Development*/Drug Development*/methods ; United States Food and Drug Administration*/United States Food and Drug Administration*/United States Food and Drug Administration*/statistics & numerical data

  • Source: Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Oct; Vol. 34 (6), pp. 818-841. Date of Electronic Publication: 2024 Mar 22.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

On the use of RWD in support of regulatory submission in drug development.

  • Authors : Chow SC; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.; Wang P

Subjects: United States Food and Drug Administration*/United States Food and Drug Administration*/United States Food and Drug Administration*/legislation & jurisprudence ; Drug Development*/Drug Development*/Drug Development*/methods ; Drug Development*/Drug Development*/Drug Development*/statistics & numerical data

  • Source: Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Oct; Vol. 34 (6), pp. 777-804. Date of Electronic Publication: 2024 Mar 19.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Oncology Combination Drug Development Strategies for Project Optimus.

  • Authors : Yap TA; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bullock J

Subjects: Drug Development* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 02; Vol. 30 (23), pp. 5237-5241.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm.

  • Authors : Hunter AM; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.; Patnaik MM

Subjects: Drug Development* ; Leukemia, Myelomonocytic, Chronic*/Leukemia, Myelomonocytic, Chronic*/Leukemia, Myelomonocytic, Chronic*/drug therapy; Humans

  • Source: Blood [Blood] 2024 Nov 07; Vol. 144 (19), pp. 1987-1992.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

An industry perspective on current QSP trends in drug development.

  • Authors : Cucurull-Sanchez L; Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Stevenage, Hertfordshire, UK. .

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Drug Industry*/Drug Industry*/Drug Industry*/methods; Humans

  • Source: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Oct; Vol. 51 (5), pp. 511-520. Date of Electronic Publication: 2024 Mar 05.Publisher: Springer Country of Publication: United States NLM ID: 101096520 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval.

  • Authors : Kamal MA; Regeneron Pharmaceuticals, Tarrytown, New York, USA.; Ganguly S

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Drug Approval*

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep; Vol. 116 (3), pp. 518-521. Date of Electronic Publication: 2024 Jul 15.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.

Subjects: United States Food and Drug Administration* ; Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Drug Development*/Drug Development*/Drug Development*/methods

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Aug; Vol. 116 (2), pp. 282-288. Date of Electronic Publication: 2024 Mar 22.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  70,941 results for ""Drug development""